Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC2A13 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
GEO DataSets Profile neighbors
HEPACAM - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
LDB3 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
MTURN - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
AGBL1 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
ZNF160 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
ARID4B - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
SCFD1 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
BIRC3 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
TRANK1 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
CNOT1 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
MSTO1 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
WDR70 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
CEP170 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on